Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation

Journal of Clinical Gastroenterology

Volumn 49, Issue 5, 2015, Pages 429-437

  Patai, Arpád ^a   Solymosi, Norbert ^b   Patai, Árpád V ^c  

^a Sopron Elizabeth Hospital   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

ERCP; indomethacin; NSAID; post ERCP pancreatitis; prevention

Indexed keywords

INDOMETACIN; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PANCREATITIS; ARTICLE; CANNULATION; CHRONIC PANCREATITIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; ADULT; ADVERSE EFFECTS; AGED; CATHETERIZATION; COMMON BILE DUCT; ENDOSCOPIC SPHINCTEROTOMY; MIDDLE AGED; PATIENT SELECTION; PROCEDURES; RECTAL DRUG ADMINISTRATION; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, RECTAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATHETERIZATION; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; COMMON BILE DUCT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; PANCREATITIS; PATIENT SELECTION; RISK FACTORS; SPHINCTEROTOMY, ENDOSCOPIC; YOUNG ADULT;

EID: 84917696344     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000168     Document Type: Article

References (49)

1. Bourke MJ. Biliary endoscopic retrograde cholangiopancreatography. Endoscopy. 2011;43:42-46.
2. Testoni PA, Testoni S, Giussani A. Difficult biliary cannulation during ERCP: how to facilitate biliary access and minimize the risk of post-ERCP pancreatitis. Dig Liver Dis. 2011;43:596-603.
3. Simon L, Dobronte Z, Patai A. Management of hypertensive dyskinesia of Oddi sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct [in Hungarian]. Orv Hetil. 1995;136:1659-1662.
4. Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425-434.
5. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc. 2004;59: 845-864.
6. Bailey AA, Bourke MJ, Kaffes AJ, et al. Needle-knife sphincterotomy: factors predicting its use and the relationship with post-ERCP pancreatitis. Gastroint Endosc. 2010;71:266-271.
7. Bailey AA, Bourke MJ, Williams SJ, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296-301.
8. Lella F, Bagnolo F, Colombo E, et al. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004; 58:830-834.
9. Cennamo V, Fuccio L, Zagari RM, et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis? A meta-Analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:2343-2350.
10. Manes G, Di Giorgio P, Repici A, et al. An analysis of the factors associated with development of complications in patients undergoing precut sphincterotomy: a prospective controlled, randomized, multicenter study. Am J Gastroenterol. 2009;104:2412-2417.
11. Cheung J, Tsoi KK, Quan W-L, et al. Guidewire versus conventional contrast cannulation of the common bile duct for prevention of post-ERCP pancreatitis: a systematic review and meta-Analysis. Gastrointest Endosc. 2009;70:1211-1219.
12. Tse F, Yuan Y, Moayyedi P, et al. Guide wire-Assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-Analysis. Endoscopy. 2013;45: 605-618.
13. Mariani A, Guissani A, Di Leo M, et al. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with contrast injection technique in low-risk and high-risk patients. Gastrointest Endosc. 2012;75:339-346.
14. Freeman ML. Post-ERCP pancreatitis: patient and techniquerelated factors. J Pancreas. 2002;3:169-176.
15. Singh P, Das A, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-Analysis of controlled trials. Gastrointest Endosc. 2004;60:544-550.
16. Andriulli A, Forlano R, Napolitano G, et al. Pancreatic duct stents in the prophylaxis of pancreatic damage after endoscopic retrograde cholangiopancretography: a systematic analysis of benefits and associated risks. Digestion. 2007;75:156-163.
17. Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42: 503-515.
18. Freeman ML, Overby C, Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59:8-14.
19. Das A, Singh P, Sivak MV Jr, et al. Pancreatic stent-placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc. 2007;65:960-968.
20. Elmunzer BJ, Higgins PD, Saini SD, et al. Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data. Am J Gastroenterol. 2013;108:410-415.
21. Akbar A, Abu Dayyeh BK, Baron TH, et al. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-Analysis. Clin Gastroenterol Hepatol. 2013;11:78-83.
22. Lankisch PG, Koop H, Winckler K, et al. Indomethacin treatment of acute experimental pancreatitis in the rat. Scand J Gastroenterol. 1978;13:629-633.
23. Wildenhain PM, Melhem MF, Birsic WI, et al. Acute hemorrhagic pancreatitis in mice: improved survival after indomethacin administration. Digestion. 1989;44:41-51.
24. Murray B, Carter R, Imrie C, et al. Diclofenac may reduce the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003;124: 1786-1791.
25. Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol. 2007;102: 978-983.
26. Montan o Loza A, Rodriguez Lomeli X, Garcia Correa JE, et al. Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes [in Spanish]. Rev Esp Enferm Dig. 2007;99:330-336.
27. Cheon YK, Cho KB, Watkins JL, et al. Efficacy of diclofenac in prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial. Gastrointest Endosc. 2007;66:1126-1132.
28. Wagh MS, Sherman S. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempts at the Holy Grail. Am J Gastroenterol. 2007;102:984-986.
29. Koshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol. 2008;23:e11-e16.
30. Senol A, Ulku S, Halil D. Efficacy of intramuscular diclofenac and fluid replacement in prevention of post-ERCP pancreatitis. World J Gastroenterol. 2009;15:3999-4004.
31. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414-1422.
32. Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47:912-917.
33. Dobronte Z, Toldy E, Ma rk L, et al. Effects of rectal indomethacin in prevention of post ERCP pancreatitis [in Hungarian]. Orv Hetil. 2012;153:990-996.
34. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines: new aspects of pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology. 1993;40:522-530.
35. Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-Analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262-1267.
36. Zheng M-H, Xia H, Chen YP. Rectal administration of NSAIDs in prevention of post-ERCP pancreatitis: a complementary meta-Analysis. Gut. 2008;57:1632-1633.
37. Yaghoobi M, Rolland S, Waschke KA, et al. Meta-Analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis. Aliment Pharmacol Ther. 2013;38:995-1001.
38. Dumonceau JM, Rigaux J, Kahaleh M, et al. Prophylaxis of post-ERCP pancreatitis: a practice survey. Gastrointest Endosc. 2010;71:934-939.
39. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383-389.
40. Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62:102-111.
41. Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-Analysis. Endoscopy. 2003;35:830-834.
42. Agresti A. Categorical Data Analysis. New York: Wiley; 2002: 91-101.
43. R Core Team. A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2012. Available at: http://www.R-project.org. Accessed September 19, 2013.
44. Hogan WJ, Geenen JE. Biliary dyskinesia. Endoscopy. 1988;20(suppl. 1):179-183.
45. ASGE Standards of Practice Committee. Complications of ERCP. Gastrointest Endosc. 2012;75:467-473.
46. Rabenstein T, Hahn EG. Post-ERCP pancreatitis: new momentum. Endoscopy. 2002;34:325-329.
47. Dai HF, Wang XW, Zhao K. Role of nonsteroideal antiinflammatory drugs in prevention of post-ERCP pancreatitis: a meta-Analysis. Hepatobiliary Pancreat Dis Int. 2009;8: 11-16.
48. Cennamo V, Fuccio L, Repici A, et al. Timing of precut procedure does not influence success rate and complications of the ERCP procedure: a prospective randomized comparative study. Gastrointest Endosc. 2009;69:473-489.
49. Swan MP, Alexander S, Moss A, et al. Needle knife sphincterotomy does not increase the risk of pancreatitis in patients with difficult biliary cannulation. Clin Gastroenterol Hepatol. 2013;11:430-436.